Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Desipramine with/without Crobenetine in Healthy Males
NCT02273466Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2002
- Primary completion
- Apr 2002
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of crobenetine in stroke (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration time curve for desipramine at steady state up to 168 hours and Maximum plasma concentration of desipramine at steady state up to 168 hours. Started Feb 2002; status: completed.
02
Drugs
crobenetine
03
Conditions
stroke
Beyond the preview
Go deeper on NCT02273466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02273466.